News

Burlington (NYSE:BURL) Surprises With Q4 Sales, Stock Soars

Off-price retail company Burlington Stores (NYSE:BURL) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.8% year on year to $3.28 billion. On the other hand, next quarter’s revenue guidance of $2.50 billion was less impressive, coming in 4.3% below analysts’ estimates. Its non-GAAP profit of $4.07 per share was 8% above analysts’ consensus estimates.

Chip stocks lead selloff on Wall St; tariffs in focus

Wall Street's main indexes fell on Thursday, led by a decline in chip stocks as Marvell's forecast fanned worries of slowing demand for AI infrastructure, while worries about a trade war unleashed by U.S. tariffs also weighed on sentiment. Concerns about overspending and overcapacity in the U.S. AI industry, in the face of China's cheaper DeepSeek models, paused Wall Street's bull rally in January. The tech-heavy Nasdaq is now down over 9% from its record high hit in December.

Analysis-Investors question 'Trump put' as tariffs rattle stock markets

NEW YORK (Reuters) -Investors are recalibrating how to play U.S. President Donald Trump's whipsawing policy changes, weighing that a so-called "Trump put" supporting stock market prices may be fading and that his administration is more keenly focused on the debt markets. Investors had bet strongly that Trump's agenda to lower taxes and usher in deregulation would support risk assets in a similar way to his first term when he frequently touted the stock market's performance. The so-called "Trump put," which refers to options, assumes that he will do whatever possible to keep the stock market happy.

BrightSpring Health Services’s (NASDAQ:BTSG) Q4: Beats On Revenue

Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 28.6% year on year to $3.05 billion. The company expects the full year’s revenue to be around $11.85 billion, close to analysts’ estimates. Its non-GAAP profit of $0.22 per share was in line with analysts’ consensus estimates.